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ABSTRACT
Objective: malignant colorectal polyp, defined by submucosally 
invasive adenocarcinoma, is the earliest form of clinically relevant 
colorectal cancer (CRC). After endoscopic resection additional sur-
gery may be necessary, although decision criteria remain debatable. 
The objective of this study was to assess oncologic outcomes in 
terms of locoregional disease and to identify areas of improvement 
that may facilitate patients’ management. 
Methods: retrospective study of 40 patients with T1 CRC 
endoscopically resected between 2007 and 2012. Clinicopatho-
logical features were assessed and correlated with residual disease 
(RD), defined as presence of adenocarcinoma in intestinal wall and/
or lymph nodes. 
Results: thirty-one patients underwent surgery while 9 were fol-
lowed-up. After surgery, RD was confirmed in 15 (48.4 %) patients: 
8 (53.3 %) wall disease, 5 (33 %) nodal metastasis, and 2 (13.3 %) 
with both. No recurrence was detected in the follow-up group. The 
characteristics of the lesions that were associated with DR were 
sessile configuration (p = 0.03), the degree of differentiation G3 (p 
= 0.01) and intercepted/indeterminate margins (p = 0.01). Twen-
ty-two patients were operated because of inadequate evaluation, 
mainly due to piecemeal resection, and half of them were disease 
free. Postoperative complications were found in 9 (30 %) patients, 
mainly anastomotic leakage that was associated with rectum ante-
rior resection (p = 0.03).
Conclusions: surgery should be considered in the presence of 
any risk factor for residual disease, while follow-up can be offered in 
low risk settings. Was also demonstrated a clear need for technical 
improvement in endoscopic resection and pathology evaluation in 
order to prevent unnecessary surgeries.
Key words: Malignant polyp. Postoperative complications. Resid-
ual disease. Risk factors. Submucosal invasion.
INTRODUCTION 
More than 95 % of colorectal cancer (CRC) arises from 
adenomas throughout the recognized adenoma-adenocar-
cinoma sequence (1,2). Therefore, during CRC screening 
the adenomatous lesion is the target, and its resection by 
endoscopic polypectomy has shown to reduce the risk of 
advanced adenomas and future colorectal cancer (3,4). 
With progressive technique refinements the endoscopic 
therapy became safe and effective to treat the majority of 
colorectal precursor lesions, whether they are pedunculat-
ed, sessil or flat, independently of size. By principle, pol-
yps should be resected en bloc to provide adequate evalu-
ation of resection margins and possible tumor spreading. 
If this can be easily achieved in pedunculated or smaller 
polyps, for sessil lesions larger than 2 cm, piecemeal endo-
scopic mucosal resection (EMR) is the commonly used 
technique. However, endoscopic submucosal dissection 
(ESD) has been used as an effective mode of achieving en 
bloc resection of large, sessile and flat lesions, although it 
has higher perforation rates, greater procedure duration, 
and requires a demanding learning curve (5-8).
Several terms have been used to describe carcinoma that 
is restricted to the epithelial layer without invasion into the 
lamina propria (high-grade dysplasia, carcinoma “in situ”, 
intraepithelial neoplasia) (6). Intramucosal carcinoma is a 
carcinoma characterized by invasion into the lamina propria. 
In all these situations endoscopic resection can offer a cura-
tive treatment (9). However, when the carcinoma breach-
es the muscularis mucosa and spreads to the submucosa 
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(where the lymphatic and vascular structures are), the pol-
yp is considered to have become malignant with potential 
risk for lymph nodes or distant sites metastasis (6,10,11). 
These lesions represent the earliest form of clinically rel-
evant CRC, corresponding to 0.5-8 % of the endoscopic 
resected adenomas, and in this case additional surgery may 
be necessary to ensure complete tumor clearance (12,13). 
Several studies have suggested that certain features may 
be valuable predictors of lymph node metastasis or per-
sistent residual tumor after endoscopic resection. These 
factors include deep submucosal invasion, poor or undif-
ferentiation, lymphovascular invasion, and positive resec-
tion margins (6,10,13-15). Nevertheless, the identification 
of those patients remains a challenge, in fact even in the 
presence of high-risk features residual disease is noted in 
15-20 % of the operated cases, and nodal disease is detected 
in a smaller proportion (13). Thus, around 84 % of patients 
may be undergoing significant morbidity due to unneces-
sary surgical interventions after endoscopic resection (14). 
In this sequence, we propose ourselves to perform a 
retrospective analysis on the cumulative experience in the 
management of malignant colorectal polyps resected endo-
scopically in our department. Besides studying the clini-
copathological features of patients and tumors, this work 
aims: a) to evaluate the oncologic outcomes in terms of 
locoregional disease (colorectal wall residual or recurrent 
tumor, and lymph node metastasis); and b) to study pre-
dictors and areas of work improvement that may facilitate 
patient selection for surgery versus surveillance.
PATIENTS AND METHODS 
We studied retrospectively all patients with malignant 
colonic polyps treated by endoscopic resection at the Gas-
troenterology Department of the Hospital Braga, between 
January 2007 and November 2012.  Data was collected 
through a complete review of patients’ clinical, endoscopic, 
histologic and surgical reports. This study was approved by 
the Human Research Ethics Committee of Hospital Braga.
The main inclusion criteria was a histologically proven 
submucosal invasive adenocarcinoma in a flat, sessile or 
semi-pedunculated lesion, or in case of pedunculated polyps 
a submucosal deep invasion larger than 3,000 µ from the 
neck (Haggitt level 2) or a free margin inferior to 2,000 µ (6), 
resected in our department and subsequently submitted to 
surgery or under follow-up for at least 24 months. Patients 
who did not accomplish the former or received a macro-
scopically incomplete polypectomy were excluded from 
this study.
Endoscopic resection was decided by the operator after 
macroscopic criteria assessment, as lifting sign, morpholo-
gy, friability, induration, and ulceration, according to Paris 
Classification (16). Depressed (0-IIc) and ulcerated (0-III) 
lesions weren’t removed and the patients were referred to 
surgery. Technical approach included almost always the 
injection of saline solution into the submucosa and the 
lift-and-cut technique. EMR was performed preferably en 
bloc, when impossible, the endoscopist performed a piece-
meal EMR and applied argon plasma coagulation (APC) in 
the visible vessels and the borders of some cases. 
Tumors characteristics 
Tumors were evaluated in order to macroscopic and 
microscopic parameters. Macroscopically they were clas-
sified according to: a) dimension; b) morphology (polypoid 
–pedunculated and semi-pedunculated; non-polypoid– ses-
sile and flat lesions) (16); and c) location (rectum, left colon 
and right colon, separated in the mid transverse). Specimens 
were microscopically characterized for: a) resection margin 
status; b) histological type; c) grade of differentiation; and 
d) presence of perineural or lymphovascular (lymphatic 
and venous) invasion. Resection margins were defined as: 
Tumor-free or complete (if malignant cells were not present 
within 100 µ) and incomplete margins (whenever the pre-
vious requirement was not met –intersected by diathermy 
effect or undetermined, when the exact margin and orien-
tation could not be assessed, due to piecemeal resection). 
According with the regular classification of intestinal-type 
adenocarcinoma in four grades (6), for stage of differenti-
ation we considered two groups: Well-moderately differ-
entiated (grade I-II) and poorly differentiated carcinoma 
(grade III-IV). Regarding vascular invasion, it was defined 
by the presence of cancer in an endothelia-lined channel 
surrounded by smooth-muscular cells. Lymphatic invasion 
was characterized by the presence of tumor cells within a 
true endothelial-lined channel in the absence of red blood 
cells. Ideally, the depth of submucosal invasion should be 
assessed in non-pedunculated lesions by Kikuchi classifi-
cation (Sm1, Sm2 and Sm3) (17). However, besides deep 
invasion in pedunculated polyps, this measure was not avail-
able in our pathological reports, because the majority of the 
lesions underwent piecemeal resection, and we believe also 
due to the lack of experience in this evaluation. 
Clinical approaches and outcomes
All the patients were proposed for surgical resection, 
due to an inadequate histological evaluation (incomplete 
margins or absence of deep invasion evaluation), or the 
presence of unfavorable risk factors (lymphovascular 
invasion or poor differentiation). Patients who underwent 
surgical resection received regular oncologic orientation 
and follow-up (FU). Patients that refused surgery or had 
prohibitive comorbidities were included in a follow-up 
scheme that, besides clinical evaluation, included annual 
measurement of carcinoembryonic antigen (CEA) levels 
and abdominal CT scan (colon cancers) or pelvic CT/MRI 
(rectal cancers). Control colonoscopy was performed at 
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three, six and twelve months after endoscopic resection 
and then annually repeated. In order to achieve valuable 
outcomes in FU patients, a minimal duration of 24 months 
was required. This was based in previous studies reporting 
time to recurrence up to 22 months (9).
Surgical and FU groups were both evaluated for onco-
logical outcomes, mainly locoregional disease (wall tumor 
and/or local lymph node metastasis) and distant metastasis. 
Residual disease was defined as adenocarcinoma present in 
colorectal wall in the segmentectomy sample, and recur-
rent disease as adenocarcinoma identified by colonoscopy 
during the follow-up program. Lymph node metastasis 
(LNM) were considered whenever present in the resected 
specimen or detected in radiologic FU.
Statistical analysis
Categorical variables were summarized using propor-
tions and assessed by Chi-squared and Fisher’s exact tests. 
Continuous variables were summarized using mean (+/- 
SD) and median range. T-test was used to compare con-
tinuous variables. All tests were two sided and the level of 
significance was set at p < 0.05. Statistical analysis was 
made on SPSS 20.0 for Windows®.
RESULTS 
Since 2007, 63 patients were diagnosed with malignant 
colonic polyps after endoscopic resection in our depart-
ment.  Three of those patients were immediately excluded 
because they had macroscopically incomplete polypecto-
my. Of the total 60 patients, 31 underwent complemen-
tary surgical resection, while 29 were included in the FU 
program, either by older age and/or co-morbidities (23 
patients) or surgery refusal (6 patients). Twenty patients 
in the FU were excluded because 3 of them did not accom-
plished the adequate FU, 10 had a FU considered insuffi-
cient for conclusions (less than 24 months), and 7 were lost 
during the FU program. Figure 1 represents the flowchart 
of the patients’ management.
Finally the population of this study included 40 patients, 
in which 29 were male and 11 female ( /  = 2.6/1). Mean 
age was 64.3 years (range 36-90 years) and the mean tumor 
size was 23.6 mm (range 10-50 mm). En bloc resection 
was performed in 25 patients, while 15 patients received 
endoscopic piecemeal resection. The characteristics of the 
removed tumors are listed in table I.
Patients who received complementary surgical resec-
tion had a mean age of 61.7 years. All of them had lymph 
node dissection and the mean number of retrieved lymph 
nodes was 8.7. Colorectal segmentectomy was performed 
in 22 of the patients (71%) –by laparoscopy in 14 and open 
approach in 8 patients– rectum anterior resection (RAR) 
was performed in 9 patients (29.0 %). Postoperative 
complications were found in 9 (30 %) patients, 2 anasto-
motic hemorrhages (22.2 %) and 7 anastomotic leakages 
(77.8 %). Leakage is a major concern and in our patients 
it was statistically associated with RAR procedure (p = 
0.034). Colostomy (definitive or temporary) was performed 
in 3 patients who had post-RAR anastomotic leakage.
Fig. 1. Management of 63 patients with histologic proven submucosally invasive colorectal carcinoma after endoscopic resection.
Histological proven 
submucosally invasive 
colorectal carcinoma after 
endoscopic resection (n = 63)
3 excluded for incomplete 
endoscopic resection
Surgery (n = 31) Follow-up (n = 29)
12 excluded for incomplete 
or insufficient F/UFree of disease (n = 16) Residual disease (n = 15)
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In surgically resected group, global residual disease (in 
colon wall and/or lymph nodes) was noted in 15 patients 
(48.4 %). In 8 patients (53.3 %), disease was exclusively 
limited to the colonic wall, 5 patients (33.3 %) presented 
nodal metastasis and 2 patients (13.3 %) presented both 
colonic wall residual lesion and lymph node metastasis. 
In the follow-up after surgery, no patients had recurrence.
Patients who did not undergo additional surgery and 
that accomplished the inclusion criteria had a median fol-
low-up period of 36.1 months (range, 24-52 months). The 
mean age was 73.1 years. Only one of these 9 patients had 
a risk factor for residual disease (undetermined margin). 
During the follow-up period, no evidence of recurrence 
was detected.
Outcomes according to patients and tumors character-
istics on univariate analysis are summarized in table II. 
It can be seen that gender (p = 0.04), polyp configuration 
(p = 0.03), differentiation (p = 0.02) and margin status 
(p = 0.02) were factors for colonic wall disease. No sig-
nificant correlations have been established for lymph node 
metastasis. Multivariate analysis showed that margin status 
was the only independent risk factor for wall disease (p = 
0.02; OR = 0.09; 95 % CI = 0.01-0.6). 
Looking for the classical risk factors of residual dis-
ease, besides the submucosal invasion which depth was 
not available for study, we found that incomplete margins, 
presence of lymphovascular invasion and poor differenti-
ation were the main risk factors for residual disease and, 
therefore, indications for subsequent surgery. Twenty-one 
patients (52.5 %) had only one risk factor for residual dis-
ease and 6 patients (15 %) had simultaneously two risk 
factors. Risk factors for residual disease and resultant 
outcomes are summarized in table III. Univariate analysis 
showed that the presence of only one risk factor is deter-
minant of poor outcome (p = 0.08) while the presence of 
no risk factor is strongly associated with lower incidence 
of residual disease (p = 0.13). 
When evaluating the features that determined the deci-
sion for surgery we find out that 22 patients underwent 
surgical resection because of inadequate initial specimen 
assessment –undetermined margins, intercepted margins, 
lack of depth submucosal evaluation in some cases of en 
bloc resection– and in 11 of those patients (50 %) there 
was no residual disease at the resection specimen. There 
was no significant difference between rectum or colon dis-
tribution, as it is presented in table IV. However 80 % of 
patients that besides en bloc resection and complete mar-
gins were submitted to surgical resection (due to lacking of 
depth submucosal evaluation), and 41 % of patients with 
intercepted or undetermined margins (mainly related to 
piecemeal resection) had no residual disease. 
DISCUSSION
Endoscopic resection affords patients with the typical 
advantages of minimally invasive procedures, but in T1 
(tumor invading submucosa) colorectal cancers it should 
be used selectively because of decreased certainty regard-
ing oncologic outcomes when local recurrence or LNM is 
considered (14,18). Many studies attempted the definition 
of potential predictors for locoregional residual disease, 
however the indications for subsequent colectomy ver-
sus follow-up remain controversial and still not properly 
established, persisting a surgical overtreatment rate that 
can achieve 80 % (13,14). In our 40 studied patients, only 
15 had residual disease, thus 63 % of our population was 
“cured” at colonoscopy. Contrarily to other studies (13-
15) none of the followed-up patients presented recurrent 
disease, probably in relationship with the small number of 
patients included in this group and an associated selection 
bias, since this group had only one patient with risk factor 
for locoregional disease (undetermined margins). 
Table I. Characteristics of tumors after 
endoscopic resection
Variables Total n (%) 
n = 40
Subsequent 
surgery n = 31
Follow-up
n = 9
Macroscopic
Size mm (range) 23.4 (10-50) 24.7 (10-50) 19.1 (15-25)
Location
  Rectum 12 (30.0) 10 (32.3) 2 (22.2)
  Left colon 22 (55.0) 18 (58.1) 4 (44.4)
  Right colon 6 (15.0) 3  (9.7) 3 (33.3)
Configuration
  Polypoid 16 (40.0) 11 (35.5) 5 (55.6)
  Non-polypoid 24 (60.0) 20 (64.5) 4 (44.4)
Microscopic
Margins
  Complete 16 (40.0) 8 (25.8) 8 (88.9)
  Intersected 9 (22.5) 9 (29.0) 0 (0.0)
  Undetermined 15 (37.5) 14 (45.2) 1 (11.1)
Differentiation
  Well 33 (82.5) 25 (80.6) 8 (88.9)
  Moderate 5 (12.5) 4 (12.9) 1 (11.1)
  Poorly 2 (5.0) 2 (6.5) 0 (0.0)
Angiolymphatic invasion
  Absent 35 (87.5) 26 (83.9) 9 (100.0)
  Present 5 (12.5) 5 (16.1) 0 (0.0)
Venous invasion
  Absent 38 (95.0) 29  (93.5) 9 (100.0)
  Present 2 (5.0) 2 (6.5) 0 (0.0)
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Table II. Outcomes according to patients and tumors characteristics
Wall disease Lymph node metastasis
Variables n Absent Present p value Absent Present p value
Polyp location 0.132 0.316
  Right colon 6 4 2 6 0
  Left colon 22 16 6 18 4
  Rectum 12 10 2 9 3
Polyp configuration 0.034 0.094
  Polypoid 16 15 1 11 5
  Non-polypoid 24 15 9 22 2
Size 0.356 0.495
  < 20 mm 13 13 2 12 1
  20-39 mm 22 17 5 17 5
  > 39 mm 4 2 2 3 1
Resection 0.135 0.392
  En bloc 25 21 4 22 3
  Piecemeal 15 9 6 11 4
Differentiation 0.018 0.462
  Well 32 24 8 27 5
  Moderate 6 6 0 4 2
  Poorly 2 0 2 2 0
Margin status 0.017 0.533
  Complete 16 16 0 14 2
  Incomplete 24 14 10 19 5
Lymphovascular invasion 0.278 0.332
  Absent 33 23 10 28 5
  Present 7 7 0 5 2
Table III. Outcomes according to risk factors besides submucosal invasion
Risk factors n Treatment options Outcomes p value
Surgical 
resection
Follow up LNM Wall 
disease
Wall disease 
+ LNM
Global 
locoregional 
disease (%)
One risk factor 0.008
  Incomplete margins 18 17 1 2 7 2 57.9
  Angiolymphatic invasion 3 3 0 1 0 0 33.3
  Poor differentiation 0 0 0 0 0 0 0.0
Two risk factors 0.63
   Incomplete margins + 
Angiolymphatic invasion
4 4 0 1 0 0 25.0
   Incomplete margins + 
Poor differentiation
2 2 0 0 2 0 100.0
Any risk factor 0.01
   Incomplete margins or 
angiolymphatic invasion 
or poor differentiation
27 26 1 4 8 2 51.9
No risk factor 13 5 8 1 0 0 7.7 0.01
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The possible presence of LNM is an important and 
enigmatic aspect, its incidence is reported between 6.6 
to 14.4 % (12,13,18,19) in agreement with our calculated 
rate of 17.5 % LNM. For more than 20 years investigators 
have searched for its determinants. The classical associ-
ated risk factors are depth (Sm3) submucosal invasion, 
poor differentiation, lymphovascular invasion, and tumor 
budding (20-23). Radical oncologic surgery is recom-
mended for patients with any of the previous factors (14). 
In our analysis, as would be expected, we were not able 
to establish significant associations in this field. In fact, 
besides the sample limitation of our study we also could 
not incorporate in analysis any information related to depth 
of submucosal invasion or tumor budding. Regarding lym-
phovascular invasion, usually assumed as an important 
independent factor, we found that from the 7 patients with 
lymphovascular invasion only 2 had LNM, furthermore 
lymphovascular invasion was not seen in 5 of the 7 patients 
with LNM. This is congruent with other studies (13) and 
stresses the possibility of other factors involved, as well 
as the limited sensitivity, specificity, and difficult identifi-
cation of lymphovascular invasion in small, fragmented, 
with extraction artifacts specimens. A recent exhaustive 
study on this topic demonstrated that the histopatholog-
ic factors for LNM in T1 colorectal cancers are: Grade 
3, angiolymphatic invasion, budding and the absence of 
background adenoma (18). Suh et al. did not find a signif-
icant relationship between LNM and depth of submuco-
sal invasion, indicating the need for further evaluation in 
this area. Furthermore, in the largest study comparing the 
long-term outcomes for patients with submucosal invasive 
CCR, none of the classical risk factors were associated 
with recurrence (24). Instead, the risk for local recurrence 
was significantly higher in high-risk patients (incomplete 
resection, poor differentiation, vascular invasion, depth of 
submucosal invasion more than 1,000 µ) with submuco-
sal rectal cancer than in patients with submucosal colon 
cancer when treated only with endoscopic resection. In 
another study the immunohistochemical expression pattern 
of several proteins in resected malignant polyps was also 
not associated with residual or recurrent disease (23). Thus 
there is a clear need for further evaluation in this area.
Besides LNM, other recognized oncologic outcome is 
wall residual disease, in this case the accepted risk factor is 
the margin status. When the resection margin is involved, 
or is less than 1 mm, the relapse ranges between 21 and 
33 % (25). Patients in whom margins could not be con-
clusively determined had the same incidence of residual 
disease as patients with positive margins (13). However, 
whether the requisite distance should be > 1, > 2, or > 3 mm 
or only a clear margin is still under debate (21,25-27). In 
our analysis we found a 25 % rate of local wall disease and 
the margin status showed to be an independent risk factor 
for that, mostly in sessile lesions that are our main group, in 
agreement with earlier studies as Hassan et al. pointed out 
(22,28,29). Polyp configuration, differentiation and margin 
status were also statistically relevant for wall disease. This 
point is mainly related with technical aspects, like piece-
meal resection or poor specimen orientation, so also here 
there is space for improvement in resection approach and 
specimen processing. 
When evaluating the available risk factors for residu-
al disease (incomplete margins, lymphovascular invasion 
and poor differentiation), in both operated and non-oper-
ated patients, and the resultant outcomes we verified that 
patients with any of those risk factors had a significant 
risk for locoregional disease. By opposite its absence is 
strongly associated with a decreased risk, strengthening 
the idea that submucosal invasion itself is not a sufficient 
indication for subsequent surgery.
During the analysis we verified that 22 of the operated 
patients underwent surgical approach by defect of informa-
tion –cases with inadequate margins evaluation (intercept-
ed and undetermined) and cases resected en bloc lacking 
depth submucosal assessment– without any additional 
risk factor. Half of these surgeries were unnecessary as no 
residual disease was detected, this was even higher (80 %) 
when considering the cases which only lack the depth inva-
sion assessment, in those 5 cases only one had residual 
disease (LNM). This is in accord with initial studies stating 
15-20 % potential risk for LNM in submucosally invasive 
cancers. From the recognized intrinsic tumors’ properties 
associated with this, only depth and budding evaluation 
is missing. The point here is that besides patients having 
the current associated risk factors who may be undergoing 
unnecessary operations as some Korean authors described 
(14,18), we detect that 50 % of our patients undergone 
unnecessary operations preventively by defect information 
and inadequate evaluation.
The decision whether to perform an endoscopic resec-
tion should be individualized. Size and sessile or flat 
morphology of the polyp are associated with incomplete 
endoscopic resection (30). To our knowledge there is no 
study stressing, what we believe to be a frequent western 
countries’ problem, related to poor endoscopic experience 
in ESD, the spread use of piecemeal resection in larger 
lesions, and with the poor experience of pathologists in 
evaluating submucosal behaviour of tumors without the 
complete wall specimen. We recognize the long learn-
ing curve on ESD, but these results justify some efforts 
Table IV. Patients surgically resected 
by defect indication (n = 22)
Rectum
(n = 7)
Colon
(n = 15)
No residual
disease (%)
Incomplete margins
(n = 17)
1/5 6/12 41.2 %
En bloc resection without 
depth assessment (n = 5)
2/2 2/3 80 %
Total (%) 42.9 % 53 % 50 %
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as is being done for early gastric cancer. The rectum is a 
safe and easier place for beginners (31-33), additionally 
it is the origin of significant surgical complications as we 
described, thus avoiding unnecessary morbidity would be 
highly valuable. This would also allow an immediate and 
adequate orientation of specimen and a better evaluation of 
tumor architecture, depth, lymphovascular and perineural 
invasion, budding, vertical and horizontal margins, and 
a consequent increased experience of our pathology col-
leagues (34). Another important aspect is the characteri-
zation of lesions before endoscopic resection improving 
suspicious of invasion. Sometimes macroscopic appear-
ance do not preclude a piecemeal approach, furthermore, 
smaller lesions are frequently approached in a simplistic 
manner using snare without submucosal injection, preclud-
ing adequate deep evaluation even in en bloc resections. 
New technologies on endoscopic image, as magnifying 
chromoendoscopy and narrow band imaging, will probably 
improve resection approach criteria (35,36).
The limitations of this study were small sample size, 
which can influence the prevalence of residual or recurrent 
disease after endoscopic resection, its retrospective design 
and some points of the histologic evaluation. However our 
aim was not only the detection of risk factors, we knew 
from the beginning that these predictors are being exhaus-
tively assessed in other studies, and that we do not have 
regularly some of those for clinical decision. We aimed to 
evaluate our real-life experience and consequently infer 
areas of improvement. In order to reduce overtreatment 
with surgery and its complications, it’s crucial an enhance 
in endoscopic pre-histological diagnosis of invasiveness, 
improve mucosal resection and histologic evaluation (37).
In conclusion, we corroborate other studies pointing out 
the need for surgery in the presence of any risk factor ver-
sus cautious follow-up in case of no risk factors. Moreover 
we demonstrated that a significant proportion of patients 
have been unnecessarily operated due to technical aspects 
that can be improved. Furthermore, these improvements 
would be safely introduced for rectal lesions, precluding 
the significant surgical morbidity in this area.
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